Cargando…

Editorial: The role of posttranslational modifications in polyglutamine diseases

Detalles Bibliográficos
Autores principales:	Weber, Jonasz Jeremiasz, Costa, Maria do Carmo, Scaglione, K. Matthew, Todi, Sokol V., Nguyen, Huu Phuc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466034/ https://www.ncbi.nlm.nih.gov/pubmed/37654791 http://dx.doi.org/10.3389/fnmol.2023.1271226

Ejemplares similares

Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity
por: Incebacak Eltemur, Rana Dilara, et al.
Publicado: (2022)

A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases
por: Johnson, Sean L., et al.
Publicado: (2022)

From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2014)

Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease
por: Pereira Sena, Priscila, et al.
Publicado: (2023)

Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy
por: Gogia, Neha, et al.
Publicado: (2022)

Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3
por: Luo, Haiyang, et al.
Publicado: (2023)

Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2019)

Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
por: Nguyen, Huu Phuc, et al.
Publicado: (2013)

Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging
por: Gadasheva, Yekatarina, et al.
Publicado: (2021)

Posttranslational modifications of proteins in diseased retina
por: Starr, Christopher R., et al.
Publicado: (2023)

Tubulin and Tubulin Posttranslational Modifications in Alzheimer’s Disease and Vascular Dementia
por: Santiago-Mujika, Estibaliz, et al.
Publicado: (2021)

Protein-RNA linkage and posttranslational modifications of feline calicivirus and murine norovirus VPg proteins
por: Olspert, Allan, et al.
Publicado: (2016)

Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases
por: Sambataro, Fabio, et al.
Publicado: (2017)

The Emerging Role of microRNAs in Polyglutamine Diseases
por: Dong, Xiaoyu, et al.
Publicado: (2019)

StkP- and PhpP-Mediated Posttranslational Modifications Modulate the S. pneumoniae Metabolism, Polysaccharide Capsule, and Virulence
por: Kant, Sashi, et al.
Publicado: (2023)

Phosphoproteome Profiling Reveals Circadian Clock Regulation of Posttranslational Modifications in the Murine Hippocampus
por: Chiang, Cheng-Kang, et al.
Publicado: (2017)

Posttranslational Modifications in Ferroptosis
por: Wei, Xiang, et al.
Publicado: (2020)

Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
por: Xiang, Chunchen, et al.
Publicado: (2018)

Calpains as novel players in the molecular pathogenesis of spinocerebellar ataxia type 17
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2022)

The Role of PCNA Posttranslational Modifications in Translesion Synthesis
por: Shaheen, Montaser, et al.
Publicado: (2010)

Role of Posttranslational Modifications of Proteins in Cardiovascular Disease
por: Liu, Yong-Ping, et al.
Publicado: (2022)

Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation
por: Johnson, Sean L, et al.
Publicado: (2020)

Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6
por: Tsou, Wei-Ling, et al.
Publicado: (2016)

Allosteric regulation of deubiquitylase activity through ubiquitination
por: Faggiano, Serena, et al.
Publicado: (2015)

An optimal ubiquitin-proteasome pathway in the nervous system: the role of deubiquitinating enzymes
por: Ristic, Gorica, et al.
Publicado: (2014)

Posttranslational modification and microtubule stability
Publicado: (1987)

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
por: Jefferis, Roy
Publicado: (2016)

Posttranslational modifications in pathogenesis of PCOS
por: Wei, Huimei, et al.
Publicado: (2022)

Posttranslational Chemical Mutagenesis Methods to Insert Posttranslational Modifications into Recombinant Proteins
por: Harel, Omer, et al.
Publicado: (2022)

Posttranslational modification of proteins : expanding nature's inventory /
por: Walsh, Christopher
Publicado: (2006)

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
por: Kuiper, E. F. E., et al.
Publicado: (2017)

The Mechanisms of Nuclear Proteotoxicity in Polyglutamine Spinocerebellar Ataxias
por: Lee, Davin, et al.
Publicado: (2020)

Editorial: The role of epigenetics in neuropsychiatric disorders
por: Shirinian, Margret, et al.
Publicado: (2022)

Live-cell super-resolution microscopy reveals a primary role for diffusion in polyglutamine-driven aggresome assembly
por: Lu, Meng, et al.
Publicado: (2019)

Regulation of Sirtuin Function by Posttranslational Modifications
por: Flick, Franziska, et al.
Publicado: (2012)

PHOSIDA 2011: the posttranslational modification database
por: Gnad, Florian, et al.
Publicado: (2011)

Posttranslational Processing and Modification of Cathepsins and Cystatins
por: Katunuma, Nobuhiko
Publicado: (2010)

Dynamics of Posttranslational Modifications of p53
por: Fan, Qing-Duan, et al.
Publicado: (2014)

Posttranslational modification of a vanadium nitrogenase
por: Heiniger, Erin K, et al.
Publicado: (2015)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u1c844hr3an48iuq1mkbimjrra